Bacteria and antibiotic response in newborns in the NICU
Part of Infections clinical trials.
This study looks at germs that cause infections in newborns and which antibiotics work best against them. It aims to help doctors choose the right treatment for babies in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 28 days old
- Your baby has been in the hospital for more than 48 hours
- Your baby did not have signs of an infection when they were admitted
- You agree to participate in this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study looks at the bacteria naturally found in breast milk. Researchers want to learn more about the germs in milk from mothers whose babies are in the neonatal intensive care unit.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study collects information about newborns in participating hospital units who have an infection confirmed by a lab test. The goal is to better understand infection patterns so care for newborns can improve.
This study looks at how the antibiotic vancomycin moves through and acts in newborn babies. It may help doctors dose the medicine more safely and effectively for babies in intensive care.
This study looks at the germ Staphylococcus aureus in newborns in the neonatal intensive care unit (NICU). It aims to track how the germ spreads and understand its genes, which could help keep other babies safe.
Hear when a new Nosocomial Infection in Neonatal Intensive Care Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.